Tectonic Therapeutic, Inc. (TECX)
22.05
+0.16
(+0.73%)
USD |
NASDAQ |
Nov 10, 16:00
22.05
0.00 (0.00%)
After-Hours: 20:00
Tectonic Therapeutic Market Cap : 424.14M for Nov. 10, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 09, 2026 | 421.06M |
| November 06, 2026 | 397.01M |
| November 05, 2026 | 373.55M |
| November 04, 2026 | 390.47M |
| November 03, 2026 | 365.08M |
| November 02, 2026 | 365.08M |
| October 30, 2026 | 380.47M |
| October 29, 2026 | 394.32M |
| October 28, 2026 | 395.48M |
| October 27, 2026 | 391.24M |
| October 26, 2026 | 383.74M |
| October 23, 2026 | 386.05M |
| October 22, 2026 | 405.67M |
| October 21, 2026 | 420.10M |
| October 20, 2026 | 419.81M |
| October 19, 2026 | 406.82M |
| October 16, 2026 | 397.21M |
| October 15, 2026 | 409.71M |
| October 14, 2026 | 403.17M |
| October 13, 2026 | 409.90M |
| October 12, 2026 | 429.91M |
| October 09, 2026 | 448.76M |
| October 08, 2026 | 437.60M |
| October 07, 2026 | 436.83M |
| October 06, 2026 | 431.06M |
| Date | Value |
|---|---|
| October 05, 2026 | 444.53M |
| October 02, 2026 | 433.56M |
| October 01, 2026 | 436.06M |
| September 30, 2026 | 447.99M |
| September 29, 2026 | 448.95M |
| September 28, 2026 | 452.22M |
| September 25, 2026 | 455.30M |
| September 24, 2026 | 463.95M |
| September 23, 2026 | 480.50M |
| September 22, 2026 | 509.73M |
| September 21, 2026 | 512.23M |
| September 18, 2026 | 519.35M |
| September 17, 2026 | 523.39M |
| September 16, 2026 | 536.85M |
| September 15, 2026 | 548.40M |
| September 14, 2026 | 571.48M |
| September 11, 2026 | 558.78M |
| September 10, 2026 | 550.32M |
| September 09, 2026 | 586.29M |
| September 08, 2026 | 584.75M |
| September 04, 2026 | 591.48M |
| September 03, 2026 | 575.52M |
| September 02, 2026 | 584.37M |
| September 01, 2026 | 600.52M |
| August 31, 2026 | 575.90M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| ACADIA Pharmaceuticals, Inc. | 3.157B |
| Alnylam Pharmaceuticals, Inc. | 20.30B |
| Anika Therapeutics, Inc. | 179.88M |
| Savara, Inc. | 1.011B |
| Vericel Corp. | 3.013B |
Market Cap Related Metrics
| PEG Ratio | -0.2351 |
| Price to Book Value | 1.895 |
| Price | 22.05 |
| Earnings Yield | -21.00% |
| PEGY Ratio | -0.2351 |